Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 56,782,740
  • Shares Outstanding, K 258,821
  • Annual Sales, $ 6,206 M
  • Annual Income, $ 2,712 M
  • 60-Month Beta 0.68
  • Price/Sales 9.22
  • Price/Cash Flow 23.10
  • Price/Book 6.50
Trade VRTX with:

Options Overview

Details
  • Implied Volatility 35.04%
  • Historical Volatility 18.68%
  • IV Percentile 32%
  • IV Rank 25.74%
  • IV High 49.13% on 04/05/21
  • IV Low 30.16% on 11/11/20
  • Put/Call Vol Ratio 0.13
  • Today's Volume 8,108
  • Volume Avg (30-Day) 3,775
  • Put/Call OI Ratio 0.85
  • Today's Open Interest 99,821
  • Open Int (30-Day) 59,960

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 2.38
  • Number of Estimates 8
  • High Estimate 2.56
  • Low Estimate 2.30
  • Prior Year 2.21
  • Growth Rate Est. (year over year) +7.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
209.22 +4.86%
on 03/26/21
222.78 -1.52%
on 04/16/21
+0.40 (+0.18%)
since 03/16/21
3-Month
204.62 +7.22%
on 02/22/21
242.99 -9.71%
on 01/25/21
-6.16 (-2.73%)
since 01/15/21
52-Week
202.57 +8.31%
on 11/02/20
306.08 -28.32%
on 07/07/20
-45.37 (-17.14%)
since 04/16/20

Most Recent Stories

More News
3 Top Biotech Stocks You Shouldn't Ignore

The biotech industry got a huge boost last year as companies scrambled to find treatments and vaccines for COVID-19. After hitting a high in February, the industry fell back as cyclical stocks came into...

AMGN : 255.71 (+0.23%)
GILD : 66.87 (+1.67%)
VRTX : 219.39 (-0.77%)
Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know

Vertex Pharmaceuticals (VRTX) closed at $217.13 in the latest trading session, marking a +0.55% move from the prior day.

VRTX : 219.39 (-0.77%)
Skyhawk Therapeutics Expands Leadership Team, Appointing Elliot Ehrich MD as President and Graeme Smith PhD as SVP NonClinical Development

Skyhawk Therapeutics Expands Leadership Team, Appointing Elliot Ehrich MD as President and Graeme Smith PhD as SVP NonClinical Development

ALKS : 19.87 (+0.51%)
MRK : 77.47 (+1.06%)
VRTX : 219.39 (-0.77%)
3 Buy the Dip Stocks for a Q2 Rebound

Because long-term economic prospects look promising, buying the current dip in fundamentally sound stocks could be a smart move. Qualcomm (QCOM), Vertex Pharmaceuticals (VRTX), and Alexion Pharmaceuticals...

QCOM : 138.21 (+0.27%)
VRTX : 219.39 (-0.77%)
ALXN : 163.68 (+3.90%)
The Bullish Case for Vertex Pharmaceuticals (VRTX)

An ascending triangle pattern has formed in the chart of Vertex Pharmaceuticals (VRTX) chart. This is a bullish pattern, so the stock could soon experience a breakout. Read more to learn how to profit...

VRTX : 219.39 (-0.77%)
3 Stocks to Buy for the Genomic Revolution

Cathie Wood has been managing more than $26 billion in assets on which she has delivered robust returns over the past year. Some of her biggest bets on the healthcare industry are placed through Ark Genomic...

NVS : 88.02 (+0.94%)
REGN : 502.60 (+1.61%)
VRTX : 219.39 (-0.77%)
Biotech Stock Roundup: BLUE/BMY's CAR T Therapy Nod, KLDO's COVID-19 Study News & More

The biotech sector gains prominence with new product approvals from bluebird (BLUE)/Bristol Myers Squibb (BMY) and other coronavirus updates.

INCY : 82.68 (-0.62%)
GSK : 37.75 (+0.16%)
BMY : 65.46 (+1.58%)
VRTX : 219.39 (-0.77%)
BLUE : 28.28 (-4.85%)
VIR : 46.38 (+2.98%)
KLDO : 6.50 (-13.91%)
Huntingtons Disease Therapeutics Market to see Huge Growth by 2026 | Pfizer, Lundbeck, Prana Biotechnology, Ceregene

Market Comprehensive Study is an expert and top to bottom investigation on the momentum condition of the worldwide industry with an attention on the Global market. The report gives key insights available...

APHB : 0.32 (-20.33%)
CORX : 1.0000 (-1.96%)
GSK : 37.75 (+0.16%)
PRAN : 2.06 (unch)
VRX.TO : 30.80 (-3.33%)
VRTX : 219.39 (-0.77%)
AavantiBio Appoints Dr. Christopher Wright as Chief Medical Officer

AavantiBio, a gene therapy company focused on transforming the lives of patients with rare genetic diseases, today announced the appointment of Christopher Wright, M.D., Ph.D., as Chief Medical Officer....

CYCN : 2.58 (+3.20%)
IRWD : 10.61 (-2.12%)
VRTX : 219.39 (-0.77%)
Vertex Receives CHMP Positive Opinion for KAFTRIO(R) (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor to Treat People With Cystic Fibrosis With At Least One F508del Mutation

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the label...

VRTX : 219.39 (-0.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs...

See More

Key Turning Points

3rd Resistance Point 225.24
2nd Resistance Point 224.01
1st Resistance Point 221.70
Last Price 219.39
1st Support Level 218.16
2nd Support Level 216.93
3rd Support Level 214.62

See More

52-Week High 306.08
Fibonacci 61.8% 266.54
Fibonacci 50% 254.32
Fibonacci 38.2% 242.11
Last Price 219.39
52-Week Low 202.57

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar